Ashcroft Pharmacy Ltd

Financial Statements for the Year Ended 31 October 2025

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

Dr K K Hussain

Mrs W Malik

REGISTERED OFFICE:

45 Ashcroft Road

Stopsley

Luton

Bedfordshire

LU2 9AU

REGISTERED NUMBER:

04551378 (England and Wales)

ACCOUNTANTS:

Hargreaves Owen Ltd

Chartered Certified Accountants

Red Sky House

Fairclough Hall, Halls Green

Weston

Hertfordshire

SG4 7DP

FIXED ASSETS

Intangible assets

4

1

1

Tangible assets

5

34,583

32,638

Investments

6

440,000

440,000

474,584

472,639

CURRENT ASSETS

Stocks

17,000

17,000

Debtors

7

243,161

223,981

Investments

8

250,000

-

Cash at bank and in hand

183,753

485,812

693,914

726,793

CREDITORS

Amounts falling due within one year

9

207,115

236,071

NET CURRENT ASSETS

486,799

490,722

TOTAL ASSETS LESS CURRENT LIABILITIES

961,383

963,361

CAPITAL AND RESERVES

Called up share capital

2

2

Retained earnings

961,381

963,359

SHAREHOLDERS' FUNDS

961,383

963,361

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 October 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 October 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 19 May 2026 and were signed on its behalf by:

Dr K K Hussain - Director

1.	STATUTORY INFORMATION

Ashcroft Pharmacy Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill

Goodwill, being the amount paid in connection with the acquisition of a business in 2003, is being amortised evenly over its estimated useful life of twenty years.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Freehold property

-

straight line over 30 years

Fixtures and fittings

-

15% on cost

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 8 (2024 - 8 ) .

4.	INTANGIBLE FIXED ASSETS

Goodwill

£

COST

At 1 November 2024

and 31 October 2025

119,999

AMORTISATION

At 1 November 2024

and 31 October 2025

119,998

NET BOOK VALUE

At 31 October 2025

1

At 31 October 2024

1

5.	TANGIBLE FIXED ASSETS

Fixtures

Freehold

and

property

fittings

Totals

£

£

£

COST

At 1 November 2024

119,995

22,516

142,511

Additions

-

7,200

7,200

At 31 October 2025

119,995

29,716

149,711

DEPRECIATION

At 1 November 2024

88,000

21,873

109,873

Charge for year

4,000

1,255

5,255

At 31 October 2025

92,000

23,128

115,128

NET BOOK VALUE

At 31 October 2025

27,995

6,588

34,583

At 31 October 2024

31,995

643

32,638

6.	FIXED ASSET INVESTMENTS

Other

investments

£

COST

At 1 November 2024

and 31 October 2025

440,000

NET BOOK VALUE

At 31 October 2025

440,000

At 31 October 2024

440,000

7.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Trade debtors

149,709

135,062

Other debtors

52,806

52,806

VAT

38,258

33,865

Prepayments

2,388

2,248

243,161

223,981

8.	CURRENT ASSET INVESTMENTS

2025

2024

£

£

Unlisted investments

250,000

-

9.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Trade creditors

134,402

164,779

Corporation tax

12,511

60,807

PAYE

310

181

Directors Current Account

51,050

1,627

Net wages

8,356

7,219

Accrued expenses

486

1,458

207,115

236,071